TMCLIFE | TMC LIFE SCIENCES BERHAD
0.490 (3.16%)
T-O (am): 0.000 (08:59:00)T-O (pm): 0.485 (14:29:00)
Price updated as of: 16:50
Fundamental
Technical
Total Score
TMCLIFE Fundamental Trend
FCON: | Sharpe Ratio: | LTS:
TMCLIFE Quarter Reports
Customize
Select columns required and click "Update" to save your preferences
| Ann. Date | Qtr. Date | Q | FYE | Revenue [M] | PBT [M] | NP [M] | NPM | DPS | EPS | R. QoQ | R. YoY | E. QoQ | E. YoY | TTM EPS |
Adj. [M] |
NP [M] (adj) |
NPM (adj) |
EPS (adj) |
E. QoQ (adj) |
E. YoY (adj) |
TTM EPS (adj) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21 Nov 25 | Q1 Sep 2025 | 1 | 30 Jun 2026 | 100.48 | 6.57 | 4.41 | 4.4% | 0.00 | 0.25 | 7.7% | 22.6% | 82.1% | 50.3% | ||||||||
| 26 Aug 25 | Q4 Jun 2025 | 4 | 30 Jun 2025 | 93.27 | 3.05 | 2.42 | 2.6% | 0.19 | 0.14 | 3.8% | 25.8% | 400.6% | 136.6% | ||||||||
| 21 May 25 | Q3 Mar 2025 | 3 | 30 Jun 2025 | 89.87 | 0.05 | -0.81 | -0.9% | 0.00 | -0.05 | 11.7% | 4.4% | 14.9% | 108.1% | ||||||||
| 10 Feb 25 | Q2 Dec 2024 | 2 | 30 Jun 2025 | 80.43 | -0.49 | -0.95 | -1.2% | 0.00 | -0.05 | 1.9% | 14.2% | 132.2% | 106.5% | ||||||||
| 18 Nov 24 | Q1 Sep 2024 | 1 | 30 Jun 2025 | 81.97 | 4.46 | 2.94 | 3.6% | 0.00 | 0.17 | 10.6% | 11.3% | 186.7% | 80.6% | ||||||||
| 21 Aug 24 | Q4 Jun 2024 | 4 | 30 Jun 2024 | 74.12 | 0.34 | 1.02 | 1.4% | 2.22 | 0.06 | 13.9% | 12.4% | 89.7% | 92.3% | ||||||||
| 23 May 24 | Q3 Mar 2024 | 3 | 30 Jun 2024 | 86.07 | 12.46 | 9.96 | 11.6% | 0.00 | 0.57 | 8.2% | 5.5% | 31.4% | 30.3% | ||||||||
| 02 Feb 24 | Q2 Dec 2023 | 2 | 30 Jun 2024 | 93.78 | 19.68 | 14.52 | 15.5% | 0.00 | 0.83 | 1.5% | 27.9% | 4.1% | 164.6% | ||||||||
| 14 Nov 23 | Q1 Sep 2023 | 1 | 30 Jun 2024 | 92.44 | 20.14 | 15.14 | 16.4% | 0.00 | 0.87 | 9.2% | 28.6% | 14.3% | 143.1% | ||||||||
| 22 Aug 23 | Q4 Jun 2023 | 4 | 30 Jun 2023 | 84.65 | 12.59 | 13.24 | 15.7% | 0.84 | 0.76 | 3.8% | 19.6% | 7.3% | 43.6% | ||||||||
| 23 May 23 | Q3 Mar 2023 | 3 | 30 Jun 2023 | 81.58 | 11.89 | 14.29 | 17.5% | 0.00 | 0.82 | 11.2% | 33.6% | 160.4% | 105.1% | ||||||||
| 08 Feb 23 | Q2 Dec 2022 | 2 | 30 Jun 2023 | 73.34 | 7.68 | 5.49 | 7.5% | 0.00 | 0.32 | 2.0% | 23.9% | 11.8% | 20.5% | ||||||||
| 16 Nov 22 | Q1 Sep 2022 | 1 | 30 Jun 2023 | 71.87 | 8.73 | 6.23 | 8.7% | 0.00 | 0.36 | 1.5% | 36.4% | 73.5% | 53.9% | ||||||||
| 23 Aug 22 | Q4 Jun 2022 | 4 | 30 Jun 2022 | 70.80 | 10.35 | 23.47 | 33.1% | 0.28 | 1.35 | 15.9% | 32.6% | 236.8% | 525.3% | ||||||||
| 26 May 22 | Q3 Mar 2022 | 3 | 30 Jun 2022 | 61.08 | 7.46 | 6.97 | 11.4% | 0.00 | 0.40 | 3.1% | 27.2% | 0.9% | 110.2% | ||||||||
| 09 Feb 22 | Q2 Dec 2021 | 2 | 30 Jun 2022 | 59.22 | 9.05 | 6.91 | 11.7% | 0.00 | 0.40 | 12.4% | 21.4% | 70.7% | 27.9% | ||||||||
| 09 Nov 21 | Q1 Sep 2021 | 1 | 30 Jun 2022 | 52.68 | 5.32 | 4.05 | 7.7% | 0.00 | 0.23 | 1.3% | 3.6% | 7.8% | 48.0% | ||||||||
| 24 Aug 21 | Q4 Jun 2021 | 4 | 30 Jun 2021 | 53.37 | 5.70 | 3.75 | 7.0% | 0.22 | 0.22 | 11.1% | 253.3% | 13.2% | 34.0% | ||||||||
| 25 May 21 | Q3 Mar 2021 | 3 | 30 Jun 2021 | 48.03 | 4.37 | 3.32 | 6.9% | 0.00 | 0.19 | 1.6% | 37.7% | 38.6% | 177.1% | ||||||||
| 04 Feb 21 | Q2 Dec 2020 | 2 | 30 Jun 2021 | 48.79 | 6.98 | 5.40 | 11.1% | 0.00 | 0.31 | 4.0% | 4.1% | 30.6% | 20.8% | ||||||||
| 10 Nov 20 | Q1 Sep 2020 | 1 | 30 Jun 2021 | 50.83 | 10.62 | 7.78 | 15.3% | 0.00 | 0.45 | 236.5% | 3.2% | 178.0% | 2.1% | ||||||||
| 25 Aug 20 | 30 Jun 2020 | Other | 30 Jun 2020 | 15.11 | 3.68 | 2.80 | 18.5% | 0.17 | 0.16 | 56.7% | 70.7% | 165.1% | 56.7% | ||||||||
| 28 Jul 20 | 31 May 2020 | Other | 30 Jun 2020 | 34.87 | -4.55 | -4.30 | -12.3% | 0.00 | -0.25 | 31.5% | 31.8% | 163.0% | 151.5% | ||||||||
| 28 Apr 20 | 29 Feb 2020 | Other | 30 Jun 2020 | 50.89 | 8.63 | 6.82 | 13.4% | 0.00 | 0.39 | 3.1% | 12.7% | 14.2% | 9.9% | ||||||||
| 09 Jan 20 | 30 Nov 2019 | Other | 30 Jun 2020 | 52.53 | 10.66 | 7.95 | 15.1% | 0.00 | 0.46 | 2.0% | 11.4% | 23.1% | 12.5% | ||||||||
| 24 Oct 19 | Q4 Aug 2019 | 4 | 31 Aug 2019 | 51.52 | 9.63 | 6.46 | 12.5% | 0.20 | 0.37 | 0.8% | 16.0% | 22.7% | 14.9% | ||||||||
| 26 Jul 19 | Q3 May 2019 | 3 | 31 Aug 2019 | 51.13 | 10.89 | 8.36 | 16.3% | 0.00 | 0.48 | 13.2% | 28.8% | 34.7% | 75.6% | ||||||||
| 23 Apr 19 | Q2 Feb 2019 | 2 | 31 Aug 2019 | 45.16 | 8.22 | 6.21 | 13.7% | 0.00 | 0.36 | 4.2% | 8.2% | 12.2% | 1.9% | ||||||||
| 24 Jan 19 | Q1 Nov 2018 | 1 | 31 Aug 2019 | 47.16 | 9.41 | 7.07 | 15.0% | 0.00 | 0.41 | 6.2% | 20.0% | 25.6% | 36.3% | ||||||||
| 26 Jul 18 | Q3 May 2018 | 3 | 31 Aug 2018 | 44.41 | 8.00 | 5.63 | 12.7% | 0.00 | 0.32 | 11.8% | 9.1% | 18.2% | 5.5% | ||||||||
| 30 Apr 18 | Q2 Feb 2018 | 2 | 31 Aug 2018 | 39.71 | 6.40 | 4.76 | 12.0% | 0.00 | 0.27 | 4.8% | 11.8% | 24.8% | 4.8% | ||||||||
| 29 Jan 18 | Q1 Nov 2017 | 1 | 31 Aug 2018 | 41.73 | 8.32 | 6.33 | 15.2% | 0.00 | 0.36 | 6.2% | 15.3% | 43.0% | 42.6% | ||||||||
| 26 Oct 17 | Q4 Aug 2017 | 4 | 31 Aug 2017 | 39.31 | 6.75 | 11.10 | 28.2% | 0.17 | 0.64 | 3.4% | 16.3% | 86.3% | 89.0% | ||||||||
| 27 Jul 17 | Q3 May 2017 | 3 | 31 Aug 2017 | 40.69 | 8.02 | 5.96 | 14.6% | 0.00 | 0.34 | 14.6% | 16.6% | 31.1% | 10.5% | ||||||||
| 28 Apr 17 | Q2 Feb 2017 | 2 | 31 Aug 2017 | 35.51 | 6.27 | 4.54 | 12.8% | 0.00 | 0.26 | 1.9% | 13.1% | 2.4% | 38.8% | ||||||||
| 23 Jan 17 | Q1 Nov 2016 | 1 | 31 Aug 2017 | 36.20 | 6.11 | 4.44 | 12.3% | 0.00 | 0.26 | 7.1% | 15.5% | 24.4% | 33.0% | ||||||||
| 28 Oct 16 | 31 Aug 2016 | Other | 31 Aug 2016 | 33.80 | 5.42 | 5.87 | 17.4% | 0.15 | 0.34 | 3.2% | 12.4% | 8.9% | 102.8% | ||||||||
| 28 Jul 16 | 31 May 2016 | Other | 31 Aug 2016 | 34.91 | 6.43 | 5.39 | 15.4% | 0.00 | 0.32 | 11.2% | 22.5% | 64.5% | 35.3% | ||||||||
| 21 Apr 16 | 29 Feb 2016 | Other | 31 Aug 2016 | 31.39 | 4.85 | 3.27 | 10.4% | 0.00 | 0.21 | 0.2% | 18.8% | 1.9% | 12.7% | ||||||||
| 22 Jan 16 | 30 Nov 2015 | Other | 31 Aug 2016 | 31.33 | 4.88 | 3.34 | 10.7% | 0.00 | 0.24 | 4.2% | 24.8% | 15.3% | 44.7% | ||||||||
| 21 Oct 15 | 31 Aug 2015 | Other | 31 Aug 2016 | 30.07 | 4.35 | 2.89 | 9.6% | 0.00 | 0.24 | 5.5% | 29.8% | 27.3% | 297.5% | ||||||||
| 24 Jul 15 | Q4 May 2015 | 4 | 31 May 2015 | 28.50 | 2.64 | 3.98 | 14.0% | 0.14 | 0.40 | 7.9% | 17.7% | 37.0% | 48.5% | ||||||||
| 22 Apr 15 | Q3 Feb 2015 | 3 | 31 May 2015 | 26.41 | 3.20 | 2.91 | 11.0% | 0.00 | 0.32 | 5.2% | 19.5% | 26.0% | 66.7% | ||||||||
| 22 Jan 15 | 30/11/14 | 2 | 31/05/15 | 25.10 | 2.12 | 2.31 | 9.2% | 0.00 | 0.28 | 8.3% | 10.8% | 216.9% | 3.9% |
TMCLIFE Historical Dividends
TMCLIFE Financial Ratios
| EPS | 0.29 sen |
| Trailing PE (Sector Median: 26.6) | 167.2 |
| PEG | 1.67 |
| Altman Z | 0.7 |
| Beaver | 0.042 |
| Current Ratio | 1.85 |
| Debt-Equity (DE) Ratio | 0.31 |
| FCF Yield | 1.06 % |
| Revenue QoQ | 7.72 % |
| Revenue YoY | 22.58% |
| Profit QoQ | 82.13 % |
| Profit YoY | 50.31 % |
| Profit Margin (Sector Median: 7.6) | 1.4 % |
| ROE (ROIC: 0.51) | 0.59 % |
| Dividend Per Share (DPS) | 0.19 sen |
| Dividend Yield (DY) | 0.39 % |
TMCLIFE Adjusted Financial Ratios
Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports
| EPS | |
| Trailing PE (Sector Median: 26.6) | |
| Profit QoQ | |
| Profit YoY | |
| Profit Margin (Sector Median: 7.6) | |
| ROE (ROIC: 0.64) | |
| Altman Z |
TMCLIFE Fair Value
Weighted Average Fair Value:
| Discounted Cash Flow (DCF) 5% Growth | |
| Discounted Cash Flow (DCF) 10% Growth | |
| Relative Valuation |
| Graham Formula | |
| Graham Number | |
| Net Tangible Asset (NTA) | 0.49 | Consistent QR FV |
The Fair Value numbers are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The figures shown here should be taken as educational purposes only
Advanced Calculators
Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.
| Forward PE FV Calculator | |
| Latest Profit (adjusted) [M] | 4.66 |
| Expected Profit (Next QR) [M] | |
| Expected Profit (After QR above) [M] | |
| Expected Profit (After QR above) [M] | |
| Estimated Fair Value |
| Growth/Risk Fair Value Calculator | |
| Expected growth (%) | |
| Estimated downside / risk (%) | |
| Estimated New DCF Fair Value |
| Contract/Award Contribution Calculator | |
| Contract/Award Value (in Million) | |
| Estimated Contribution to Stock Price | |
| Estimated New DCF Fair Value |
| Profit-Based Calculator | |
| Expected Profit (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Revenue-Based Calculator | |
| Expected Revenue (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Market Pricing | |
| Expected Profit (M) | 319.15 |
| Expected Revenue (M) | 2690.98 |
| Expected Growth (%) | 43.0 |
The Fair Value calculated using this calculators are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The purpose of this tool is to help investor to quickly calculate their own expected Fair Value based on their own research
TMCLIFE Directors Share Purchases (Beta)
No transaction in the last 2 months.
TMCLIFE Summary
Market Cap: 850 M.
Market Cap Class: Middlers
Number of Shares: 1736 M.
Adjusted Float: 100%.
Stock highly correlated with
GENTING (95%)
SMTRACK (94%)
GENM (93%)
MAA (93%)
TMC Life Sciences Berhad, through its subsidiaries, provides a range of fertility treatment services in Malaysia. It is engaged in the development, marketing, management of healthcare programs; provision of storage of cord blood and adult stem cells, stem cell therapy, and application services. It operates women's clinic and medical center; and provides gynecological and fertility problem management, as well as consultancy, and research and development services. The company operates TMC fertility centers. The company was founded in 1994 and is headquartered in Petaling Jaya, Malaysia.
Sectors: Trading & Services, Healthcare, Health Care Providers, Penny Stocks
Code: 0101
Website: http://www.tmclife.com/
Related Links: Bursa | Annual Report | Announcement
Warrant Info:
No warrants listed
Frequently Asked Questions
TMC Life Sciences Berhad, through its subsidiaries, provides a range of fertility treatment services in Malaysia. It is engaged in the development, marketing, management of healthcare programs; provision of storage of cord blood and adult stem cells, stem cell therapy, and application services. It operates women's clinic and medical center; and provides gynecological and fertility problem management, as well as consultancy, and research and development services. The company operates TMC fertility centers. The company was founded in 1994 and is headquartered in Petaling Jaya, Malaysia. The company is listed on Bursa Malaysia and operates in the Trading & Services, Healthcare, Health Care Providers and Penny Stocks sectors.
Yes, TMC LIFE SCIENCES BERHAD is listed as Shariah-compliant.
The latest share price of TMC LIFE SCIENCES BERHAD is RM 0.490 updated on 27 January 2026 16:50.
As of now, TMC LIFE SCIENCES BERHAD has a market capitalization of 850M based on the latest financial data.
iSaham's technical analysis indicates that TMC LIFE SCIENCES BERHAD's support level is at RM 0.445 and its resistance level is at RM 0.5, based on moving averages and price patterns.
The 52-week high for TMC LIFE SCIENCES BERHAD is RM 0.495
There's no recent price movement data available for TMC LIFE SCIENCES BERHAD. Check TMC LIFE SCIENCES BERHAD’s latest performance trends using the iSaham Stock Screener.
TMC LIFE SCIENCES BERHAD declared a dividend of 0.19 sen for the year 2025-11-21. View more details on TMC LIFE SCIENCES BERHAD's Historical Dividends page.
You can buy TMC LIFE SCIENCES BERHAD shares through any licensed online broker or trading platform registered with Bursa Malaysia. If you're new to investing, iSaham can help you open an account with M+ Online, one of Malaysia's leading brokers.
When you open your M+ account through the iSaham team, you can get iSaham Pro for free as a bonus offer.
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.